greeksoup/ stock research

Intuitive Surgical (ISRG) FY2010 results: revenue $1.4 billion, up 34.3% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $1.4 billion for fiscal 2010, the year ended 31 December 2010, up 34.3% on the year before. Net income was $382 million, up 64.1%, and diluted earnings per share $1.05. The figures are the company's own, from the 10-K it filed with the SEC on 1 February 2011.

Revenue
$1.4 billion
+34.3% on the year
FY2007FY2010
Operating margin
39.3%
35.9% a year earlier
FY2007FY2010
Net income
$382 million
+64.1% on the year
FY2007FY2010
Diluted EPS
$1.05
+59.7% on the year
FY2007FY2010

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2010FY2009FY2008On the yearLast 8 years
Revenue1,4131,052875+34.3%
Cost of revenue383301254+27.2%
Gross profit1,030751621+37.1%
Gross margin72.9%71.4%71.0%
Research and development11695.179.4+22.0%
Selling, general and administrative359279231+28.8%
Operating income555377311+47.1%
Operating margin39.3%35.9%35.5%
Pre-tax income572396335+44.5%
Income tax190164131+16.5%
Effective tax rate33.3%41.3%39.0%
Net income382233204+64.1%
Net margin27.0%22.1%23.4%
Diluted EPS$1.05$0.66$0.57+59.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2010FY2009FY2008On the yearLast 8 years
Operating cash flow546392278+39.2%
Capital expenditure96.053.4106+79.7%
Free cash flow450339172+32.8%
Free cash flow margin31.8%32.2%19.7%
Cash from investing-494-300-305
Cash from financing7.7-66.298.0
Depreciation and amortisation40.434.625.1+16.8%
Share-based compensation11897.076.6+21.3%
Buybacks1991500.0+32.4%
Diluted shares, weighted363m353m359m+2.8%
Shares outstanding at period end350m346m353m+1.0%

Balance sheet

$ millionFY2010FY2009FY2008On the yearLast 8 years
Shareholders' equity2,0371,5371,267+32.5%
Debt0.0n/an/a
Other liabilities353272208+29.6%
Total liabilities and equity2,3901,8101,475+32.1%
Fixed assets160126117+27.1%
Goodwill117111111+5.6%
Intangible assets66.156.256.2+17.6%
Investments1,329951707+39.8%
Trading assetsn/a62.2n/a
Cash and equivalents280221195+26.4%
Receivables247205170+20.2%
Inventory86.857.663.5+50.7%
Other assets10519.855.2+429.7%
Total assets2,3901,8101,475+32.1%

10-K for the year ended 31 December 2010, filed 1 February 2011: the filing.